Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2014, Article ID 485178, 3 pages
http://dx.doi.org/10.1155/2014/485178
Case Report

Management of Gamma-Butyrolactone Dependence with Assisted Self-Administration of GBL

Department of Consultation-Liaison Psychiatry, University Hospital Zurich, Ramistraße 100, 8091 Zurich, Switzerland

Received 24 April 2014; Accepted 17 June 2014; Published 26 June 2014

Academic Editor: Paola Sandroni

Copyright © 2014 Rafael Meyer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. L. Nicholson and R. L. Balster, “GHB: a new and novel drug of abuse,” Drug and Alcohol Dependence, vol. 63, no. 1, pp. 1–22, 2001. View at Google Scholar · View at Scopus
  2. L. J. Schep, K. Knudsen, R. J. Slaughter, J. A. Vale, and B. Mégarbane, “The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol,” Clinical Toxicology, vol. 50, no. 6, pp. 458–470, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. McDonough, N. Kennedy, A. Glasper, and J. Bearn, “Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review,” Drug and Alcohol Dependence, vol. 75, no. 1, pp. 3–9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Dyer, B. Roth, and B. A. Hyma, “Gamma-hydroxybutyrate withdrawal syndrome,” Annals of Emergency Medicine, vol. 37, no. 2, pp. 147–153, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Bay, L. F. Eghorn, A. B. Klein, and P. Wellendorph, “GHB receptor targets in the CNS: focus on high-affinity binding sites,” Biochemical Pharmacology, vol. 87, no. 2, pp. 220–228, 2014. View at Publisher · View at Google Scholar
  6. S. B. Vogensen, A. Marek, T. Bay et al., “New synthesis and tritium labeling of a selective ligand for studying high-affinity gamma-hydroxybutyrate (GHB) binding sites,” Journal of Medicinal Chemistry, vol. 56, no. 20, pp. 8201–8205, 2013. View at Google Scholar
  7. E. Sigel and M. E. Steinmann, “Structure, function, and modulation of GABAA receptors,” The Journal of Biological Chemistry, vol. 287, no. 48, pp. 40224–40231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. de Jong, R. Kamal, B. A. Dijkstra, and H. A. de Haan, “Gamma-hydroxybutyrate detoxification by titration and tapering,” European Addiction Research, vol. 18, no. 1, pp. 40–45, 2012. View at Publisher · View at Google Scholar · View at Scopus